What Are the Best Supplements for Parkinson’s Disease?

No supplement has been convincingly shown to slow the progression of Parkinson’s disease in large, well-designed human trials. That is the honest starting point. But the picture is more nuanced than a blanket “nothing works,” because several supplements do address specific Parkinson’s-related symptoms, correct common deficiencies, or show enough early promise that researchers are actively running bigger studies. The challenge is separating the handful with real evidence behind them from the much longer list of compounds that looked great in a petri dish but never panned out in people.

Supplements That Failed in Large Trials

Before looking at what might help, it is worth understanding what has already been tested and found lacking. This saves you money and steers attention toward options with more realistic expectations.

Coenzyme Q10 (CoQ10) is probably the most-discussed supplement in Parkinson’s circles. An early small trial found that a high dose appeared to slow functional decline compared to placebo, with a statistically significant difference at the highest dose tested.¹ That generated real excitement. But when a much larger trial followed up with even higher doses, the results were flatly negative. Both the moderate and high-dose CoQ10 groups actually trended slightly worse than placebo, and neither difference reached significance.² A meta-analysis pooling results from multiple randomized trials confirmed the finding: CoQ10 was safe and well tolerated, but no better than placebo for motor symptoms.³

Creatine monohydrate followed a similar trajectory. A small pilot trial suggested it might reduce the need for increased medication doses and improve mood, though it did not change overall symptom scores.⁴ A large, multi-year follow-up study settled the question: creatine for at least five years did not improve clinical outcomes compared to placebo.⁵

Vitamin E supplementation also disappointed. A landmark trial tested high-dose tocopherol (the form of vitamin E used in most supplements) in early Parkinson’s and found no beneficial effect on disease progression.⁶ This is an important distinction, though, because dietary vitamin E intake tells a different story. Two separate meta-analyses of observational studies found that people whose diets were naturally high in vitamin E had a lower risk of developing Parkinson’s in the first place, with about a 13-20% reduction in risk for the highest intake groups.⁷⁸ Neither analysis found a similar protective effect for vitamin C. The takeaway: eating foods rich in vitamin E (nuts, seeds, leafy greens) may matter for prevention, but popping vitamin E capsules after diagnosis does not appear to help.

Vitamin D and Parkinson’s

Vitamin D deficiency is strikingly common in people with Parkinson’s. Researchers noticed this pattern almost two decades ago, and the association has been replicated many times since.⁹ Lower vitamin D levels correlate with worse motor symptom scores and greater disease severity, though not with the age symptoms first appeared or how long someone has had the disease.⁹ Fall risk, already a major concern in Parkinson’s, is also associated with lower vitamin D. A recent study in deficient patients found a clear negative correlation between vitamin D levels and motor symptom severity scores, and supplementation with vitamin D3 was linked to changes in immune markers thought to play a role in Parkinson’s pathology.¹⁰

A meta-analysis of randomized controlled trials looking specifically at whether vitamin D supplementation improves motor symptoms found that lower serum levels are associated with more severe motor symptoms.¹¹ Whether supplementation truly reverses that or whether low vitamin D is just a marker of worse disease remains an open question. Still, given that deficiency is so common and that correcting it is cheap, safe, and potentially protective against falls and bone fractures, most neurologists consider vitamin D testing and supplementation a reasonable step for anyone with Parkinson’s.

B Vitamins and the Levodopa Connection

If you take levodopa, the most common Parkinson’s medication, B vitamins become relevant in a way that goes beyond general nutrition. When your body processes levodopa, one of the metabolic pathways involved uses up vitamins B12, B6, and folate as co-factors. Over time, this can deplete those vitamins and drive up blood levels of homocysteine, a compound linked to cognitive decline and cardiovascular problems.¹² The accumulating deficiencies appear to be the substrate for this homocysteine elevation, and B-vitamin supplementation can bring levels back down.¹²

This is not about slowing Parkinson’s itself but about managing a downstream effect of its most important treatment. If you have been on levodopa for a while and have not had your homocysteine or B vitamin levels checked, it is worth discussing with your doctor. A simple blood test can flag the problem, and a B-complex supplement or dietary adjustments can address it.

Nicotinamide Riboside, the Most Watched Newcomer

Nicotinamide riboside (NR), a form of vitamin B3 that boosts levels of NAD+ in cells, has generated more recent excitement in Parkinson’s research than perhaps any other supplement. NAD+ is a molecule central to energy production in cells, and its levels decline with age and in neurodegenerative disease. The idea behind NR is straightforward: replenish NAD+ and give struggling neurons more fuel.

The first clinical trial, called NADPARK, gave newly diagnosed, untreated patients either 1,000 mg of NR or placebo for 30 days. NR significantly raised NAD+ levels in both blood and brain. In patients whose brain NAD+ levels actually went up (not everyone’s did), researchers saw changes in brain metabolism and a trend toward mild clinical improvement. The treatment also reduced inflammatory markers in blood and spinal fluid.¹³ An important detail from that trial was the variability: some patients responded robustly while others saw minimal NAD+ increase, suggesting that individual biology matters a lot in how well NR works.¹⁴

A follow-up safety trial called NR-SAFE tested a much higher dose of 3,000 mg daily. At that dose, whole blood NAD+ levels rose roughly fourfold. The NR group showed a statistically significant decrease in total Parkinson’s symptom scores, driven mainly by improvements in motor symptoms.¹⁵ These are still relatively small, short trials, and NR is not ready to be called a proven treatment. But among the supplement candidates currently being studied for Parkinson’s, NR has some of the most encouraging early clinical data. Larger, longer trials are underway.

N-Acetyl Cysteine (NAC)

NAC is a precursor to glutathione, one of the body’s main antioxidant defenses. People with Parkinson’s tend to have depleted glutathione in the brain regions affected by the disease, making NAC a logical candidate for supplementation. A randomized trial gave patients both intravenous and oral NAC for three months and found something striking: dopamine transporter binding in key brain areas increased by roughly 3-8%, along with significant symptom improvement.¹⁶

The catch is that the protocol used intravenous infusions, not just pills. A pharmacokinetic study found that oral NAC alone had low bioavailability and did not significantly raise brain glutathione levels.¹⁷ So while NAC shows genuine promise, the version you can buy over the counter and swallow as a capsule may not deliver enough to the brain to matter. The research moving forward will need to sort out whether oral-only regimens can work at higher doses or whether the intravenous component is what made the difference.

Omega-3 Fatty Acids for Depression in Parkinson’s

Depression affects a large proportion of people with Parkinson’s, and it is often undertreated. Omega-3 fatty acids from fish oil have been studied specifically for this non-motor symptom. A placebo-controlled pilot trial found that patients taking fish oil showed significant improvement in depression scores, and about 40% of the fish oil group met criteria for a meaningful reduction in depressive symptoms.¹⁸ A systematic review of randomized trials confirmed that beneficial effects have been reported for depression, as well as for inflammation and oxidative stress markers.¹⁹

Omega-3s are not going to change your motor symptoms, and nobody is claiming they slow disease progression. But if depression is part of your Parkinson’s experience, fish oil is inexpensive, generally safe, and has at least pilot-level evidence behind it as either a standalone or add-on approach.

Mucuna Pruriens, a Natural Levodopa Source

Mucuna pruriens is a tropical legume whose seeds naturally contain levodopa, the same active compound in the standard Parkinson’s medication. This is not a supplement that might theoretically help through some indirect mechanism; it delivers the actual drug. A double-blind study in patients found that a 30-gram mucuna preparation produced a considerably faster onset of effect than standard levodopa/carbidopa, with about half the latency to peak effect. The “on” time, when symptoms are well controlled, lasted roughly 22% longer with mucuna, and peak levodopa blood levels were more than double those from the conventional drug.²⁰

A more recent randomized controlled trial from Asia reinforced these findings, reporting that mucuna provided a significantly longer period of symptom control without dyskinesia compared to conventional levodopa.²¹ A systematic review of clinical trials noted that mucuna was consistently associated with faster time to the “on” state, longer duration of symptom control, and fewer adverse events, with no dyskinesia reported.²²

There are real caveats. Mucuna supplements vary widely in levodopa content from brand to brand, and unlike pharmaceutical levodopa, they are not standardized or combined with carbidopa (which helps levodopa reach the brain). Using mucuna without medical supervision carries a genuine risk of under- or overdosing. In parts of the world where pharmaceutical levodopa is expensive or unavailable, mucuna represents a meaningful alternative, but in settings where conventional medications are accessible, it is best treated as something to discuss with a neurologist rather than to self-administer.

Probiotics and the Gut-Brain Connection

Constipation is one of the most common and earliest non-motor symptoms of Parkinson’s, and it is more than just an inconvenience. Emerging research ties gut health directly to how the disease behaves. Probiotics have been tested specifically for Parkinson’s-related constipation in multiple trials. A meta-analysis found that probiotic treatment significantly increased bowel movement frequency by about one extra movement per week and improved stool consistency.²³

Individual trials have been more specific. One 12-week study found that about half of probiotics users saw meaningful improvement in constipation compared to less than a tenth on placebo, with improvements in stool consistency, symptom burden, and quality of life.²⁴ Another trial showed probiotic users had five times higher odds of achieving adequate bowel frequency and significantly reduced gut transit time.²⁵

There is also growing interest in prebiotics, which feed beneficial gut bacteria, and in short-chain fatty acids (SCFAs) produced by those bacteria. A recent randomized trial found that six months of supplementation with SCFAs and a prebiotic led to clinically meaningful improvements in motor scores, reduced medication requirements, and even improved sense of smell and cognitive function.²⁶ The effects went beyond constipation relief, suggesting that supporting gut health may influence the disease more broadly. Animal studies show that prebiotics can boost butyrate-producing bacteria, reduce alpha-synuclein accumulation in the gut, and decrease neuroinflammation.²⁷ Dietary fiber is the simplest way to feed these bacteria in practice.²⁸

Compounds Still Stuck in the Lab

Several supplements get a lot of attention online based on impressive-sounding laboratory results, but they lack human clinical trial data in Parkinson’s patients. It is worth knowing what has not yet crossed over from bench to bedside.

Curcumin, the active compound in turmeric, can protect neurons from alpha-synuclein toxicity in cell cultures and reduce related oxidative damage.²⁹ Lab studies show it binds to the toxic clumps of alpha-synuclein that are a hallmark of Parkinson’s and can alter their structure.³⁰ Animal studies with advanced delivery methods have shown curcumin can cross the blood-brain barrier and improve motor function in mouse models.³¹ The problem is that curcumin is notoriously poorly absorbed from the gut, and no controlled human trial has shown clinical benefit in Parkinson’s. The gap between what curcumin can do in a lab dish and what a turmeric capsule does in your body is enormous.

Alpha-lipoic acid and green tea polyphenols are in a similar position. Multiple animal studies show that alpha-lipoic acid protects dopamine-producing neurons by reducing inflammation and boosting antioxidant defenses.³²³³ Green tea catechins have shown neuroprotective effects in toxin-treated mice, preventing iron and alpha-synuclein buildup in the brain region most affected by Parkinson’s.³⁴ These are encouraging findings for drug development, but they are not reasons to self-prescribe these supplements for Parkinson’s today.

Melatonin and Sleep Symptoms

Many people with Parkinson’s experience REM sleep behavior disorder, a condition where you physically act out dreams during sleep. Melatonin is sometimes recommended for this. A randomized controlled trial tested prolonged-release melatonin at 4 mg in Parkinson’s patients with this sleep problem and found no difference between melatonin and placebo in reducing the frequency of episodes.³⁵ Melatonin may still help with general sleep quality, but the evidence for its most talked-about Parkinson’s-specific use is not encouraging.

Supplements That Can Do Harm

Iron supplements deserve particular caution. Iron accumulates in the brain regions damaged by Parkinson’s, and excessive iron is thought to contribute to oxidative damage. A prospective study found that iron supplement intake was significantly associated with increased risk of developing parkinsonism, with users facing roughly 70% higher risk.³⁶ An earlier study found that people in the highest quartile of dietary iron intake had about a 70% higher risk of Parkinson’s as well, and when high iron was combined with high manganese intake, the risk nearly doubled.³⁷ Unless you have confirmed iron-deficiency anemia, iron supplementation is generally something to avoid if you have or are at risk for Parkinson’s.

Iron supplements also create a practical problem for people taking levodopa. Ferrous sulfate can interfere with levodopa absorption, reducing the medication’s effectiveness.³⁸ If iron supplementation is medically necessary, timing it as far apart from levodopa doses as possible is critical.

Timing Supplements Around Levodopa

The interaction between levodopa and what you eat or take alongside it is one of the most practical things you can learn. Amino acids from dietary protein compete with levodopa for absorption in the gut and for transport into the brain. High-protein meals taken near a levodopa dose can blunt the medication’s effect, leading to more “off” time when symptoms break through.³⁹

Protein redistribution diets, where you eat most of your daily protein at the last meal rather than spreading it through the day, have been shown to be more effective than simple low-protein diets for improving levodopa bioavailability.⁴⁰ Modeling studies support this approach, showing that concentrating amino acid intake into one meal, and taking levodopa in the fasted periods, can meaningfully increase the time the drug is above therapeutic levels.⁴¹

This means protein-containing supplements like whey protein or branched-chain amino acids should not be taken close to a levodopa dose. The same review that flagged iron found positive interactions for levodopa with coffee, fiber, and vitamin C.³⁸ Vitamin C in particular may enhance levodopa absorption, which makes timing it alongside your medication potentially useful rather than harmful.

Supplement Quality and Contamination

One issue that does not get enough attention is the quality of what you are actually swallowing. Supplements are not regulated like pharmaceuticals, and the contents of a capsule do not always match the label. This matters especially for botanicals like mucuna pruriens, where the levodopa content can vary enormously between brands and batches. A review of plant-based antioxidant supplements also flagged the risk of contamination with harmful compounds, including mycotoxins, in marketed products.⁴² If you decide to try any supplement, choosing brands that have been independently tested by a third-party lab helps reduce the chance of getting a contaminated or inaccurately labeled product.